• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌初始放化疗后行 FDG-PET 引导颈部管理的经济学分析。

Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.

机构信息

Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.

出版信息

Head Neck. 2013 Sep;35(9):1287-94. doi: 10.1002/hed.23108. Epub 2012 Sep 18.

DOI:10.1002/hed.23108
PMID:22987817
Abstract

BACKGROUND

The aim of this economic analysis was to model different strategies using pre-treatment nodal stage or nodal response assessment with CT or positron emission tomography (PET)/CT to determine the need for neck dissection.

METHODS

A cost-minimization analysis was developed on the basis of probability data from a prospective study of PET-guided management of the neck in patients achieving a complete response at the primary site. Costs were derived from our institution's activity-based clinical costing system. The effect of uncertainty was tested with sensitivity and scenario analyses including nationally representative cost data.

RESULTS

Strategies incorporating PET had a 7% rate for neck dissection compared with 44% for CT-guided and 90% for planned neck dissection. The cost per patient was A$16,502 for planned neck dissection, A$8014 for CT-guided, and A$2573 for PET-guided. A policy with PET used only for incomplete response on CT was the least-cost strategy (A$2111). Policies incorporating PET remained the most efficient for all sensitivity/scenario analyses.

CONCLUSION

The incorporation of PET/CT into nodal response assessment significantly reduced the number of unnecessary neck dissections and generated considerable cost savings in our cohort.

摘要

背景

本经济分析旨在通过使用 CT 或正电子发射断层扫描(PET)/CT 进行治疗前淋巴结分期或淋巴结反应评估来制定不同的策略,以确定是否需要进行颈部清扫术。

方法

根据一项前瞻性研究中关于 PET 指导颈部管理的概率数据,在基于活动的临床成本核算系统的基础上制定了成本最小化分析。采用敏感性分析和情景分析对不确定性进行了测试,其中包括具有代表性的全国性成本数据。

结果

与 CT 引导和计划颈部清扫组(分别为 44%和 90%)相比,纳入 PET 的策略组颈部清扫的比例为 7%。计划颈部清扫的每位患者的费用为 16502 澳元,CT 引导的费用为 8014 澳元,PET 引导的费用为 2573 澳元。仅对 CT 显示不完全反应的患者使用 PET 的策略是成本最低的策略(2111 澳元)。在所有敏感性/情景分析中,纳入 PET 的策略仍然是最有效的策略。

结论

在淋巴结反应评估中纳入 PET/CT 可显著减少不必要的颈部清扫术数量,并为我们的患者群体带来显著的成本节约。

相似文献

1
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.头颈部鳞状细胞癌初始放化疗后行 FDG-PET 引导颈部管理的经济学分析。
Head Neck. 2013 Sep;35(9):1287-94. doi: 10.1002/hed.23108. Epub 2012 Sep 18.
2
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.PET-NECK:一项多中心随机III期非劣效性试验,比较正电子发射断层扫描-计算机断层扫描引导下的观察等待策略与计划性颈部清扫术在治疗头颈部鳞状细胞癌局部晚期(N2/N3)淋巴结转移中的效果。
Health Technol Assess. 2017 Apr;21(17):1-122. doi: 10.3310/hta21170.
3
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.晚期口咽鳞状细胞癌放化疗后计划性颈清扫术:超声、磁共振成像及氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在评估颈部残留病灶中的作用
J Craniomaxillofac Surg. 2014 Dec;42(8):1834-9. doi: 10.1016/j.jcms.2014.06.023. Epub 2014 Jul 9.
4
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.在采用氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)引导的颈部处理策略后,N3(>6 cm)头颈部鳞状细胞癌患者接受原发性放化疗后的结果。
Head Neck. 2014 Aug;36(8):1200-6. doi: 10.1002/hed.23434. Epub 2013 Oct 19.
5
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.PET-CT 监测与颈部清扫术在头颈部晚期癌症中的应用。
N Engl J Med. 2016 Apr 14;374(15):1444-54. doi: 10.1056/NEJMoa1514493. Epub 2016 Mar 23.
6
The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.CT和¹⁸F-FDG PET在放化疗后颈部淋巴结阳性的头颈癌治疗中的作用。
Acta Otolaryngol. 2009 Aug;129(8):893-9. doi: 10.1080/00016480802441747.
7
Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.PET-CT引导下局部晚期头颈癌管理的成本效益分析。
Eur J Cancer. 2017 Nov;85:6-14. doi: 10.1016/j.ejca.2017.07.054. Epub 2017 Sep 4.
8
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.正电子发射断层扫描在头颈部鳞状细胞癌患者根治性放化疗后检测颈部残留淋巴结疾病的能力。
Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40. doi: 10.1001/archotol.133.5.435.
9
Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.胸部 CT 和全身 18F-FDG PET 在筛查头颈部癌症患者的远处转移方面具有成本效益。
J Nucl Med. 2010 Feb;51(2):176-82. doi: 10.2967/jnumed.109.067371.
10
Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.器官保留治疗后,正电子发射断层扫描引导下颈部处理在淋巴结阳性头颈癌中的长期结果。
Oral Oncol. 2015 Mar;51(3):260-6. doi: 10.1016/j.oraloncology.2014.12.009. Epub 2014 Dec 29.

引用本文的文献

1
Role of F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications.F-FDG PET/CT在头颈部鳞状细胞癌中的作用:当前证据与创新应用
Cancers (Basel). 2024 May 16;16(10):1905. doi: 10.3390/cancers16101905.
2
Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.将 MR 扩散成像和 T2 信号强度添加到术后口腔癌原发部位的颈成像报告和数据系统分类 2 和 3 中可提供附加诊断价值。
AJNR Am J Neuroradiol. 2022 Jul;43(7):1018-1023. doi: 10.3174/ajnr.A7553. Epub 2022 Jun 23.
3
Value-based Healthcare: Applying Time-driven Activity-based Costing in Orthopaedics.
基于价值的医疗保健:时间驱动作业成本法在骨科中的应用。
Clin Orthop Relat Res. 2018 Dec;476(12):2318-2321. doi: 10.1097/CORR.0000000000000552.
4
Defining value-driven care in head and neck oncology.定义头颈肿瘤学中的价值驱动型医疗。
Curr Oncol Rep. 2015 Jan;17(1):424. doi: 10.1007/s11912-014-0424-y.
5
The economic burden of head and neck cancer: a systematic literature review.头颈癌的经济负担:一项系统的文献综述
Pharmacoeconomics. 2014 Sep;32(9):865-82. doi: 10.1007/s40273-014-0169-3.
6
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.放化疗后 F-18-FDG PET/CT 预测人乳头瘤病毒相关性口咽癌局部区域失败的可靠性。
Oral Oncol. 2014 Mar;50(3):234-9. doi: 10.1016/j.oraloncology.2013.12.003. Epub 2013 Dec 31.